Clinical trial CHANCES-IPC 2021-008
A phase 1 first-in-human study of the anticd73 iph5301 alone or in combination with chemotherapy and trastuzumab in patients with advanced solid tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Oui |
| Sponsor | Unicancer |
| EudraCT Identifier | 2023-504605-36-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05143970 |
| Last update |